Neuronetics Dividends
| STIM Stock | USD 1.58 0.22 12.22% |
As of the 14th of February 2026, Dividend Paid And Capex Coverage Ratio is likely to drop to -19.98. Neuronetics' past performance could be the main factor of why investors trade Neuronetics stock today. Investors should clearly understand every aspect of the Neuronetics dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Neuronetics' dividend schedule and payout information. Neuronetics dividends can also provide a clue to the current valuation of Neuronetics.
| Last Reported | Projected for Next Year | ||
| Dividend Paid And Capex Coverage Ratio | (19.03) | (19.98) |
Neuronetics | Build AI portfolio with Neuronetics Stock |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Neuronetics must own a stock before its ex-dividend date to receive its next dividend.
Will Health Care Equipment & Supplies sector continue expanding? Could Neuronetics diversify its offerings? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Neuronetics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.83) | Revenue Per Share | Quarterly Revenue Growth 1.013 | Return On Assets | Return On Equity |
Neuronetics's market price often diverges from its book value, the accounting figure shown on Neuronetics's balance sheet. Smart investors calculate Neuronetics' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Neuronetics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.